4-CHLORO-7-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(2,2,2-TRIFLUOROETHYL)-1H -INDAZOL-3-AMINE
UNII GUY7697BLX
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-1h -indazol-3-amine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GUY7697BLX.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2189684-53-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C15H18BClF3N3O2 UPVNVWWQWJYPRN-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-1h -indazol-3-amine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.